EGF Skincare From Korea: A Founder's Guide to sh-Oligopeptide-1

In Korean skincare, EGF is a familiar name on ampoules, sheet masks, and after-care creams. It rides the same clinic-inspired wave as PDRN and exosomes.

For an indie founder, that familiarity hides three problems. China bans the ingredient in cosmetics. Its science sits close to US drug rules. And researchers openly question whether cosmetic grades do what the marketing says.

My first question to any founder who asks for an “EGF serum” is simple: which EGF, and for which market? The answers change the name on your label, the claims you can print, and where you can sell.

What Is EGF, and Why Is It Called sh-Oligopeptide-1?

EGF is a small signaling protein, 53 amino acids long, that binds receptors on skin cells and tells them to grow, move, and renew. Cosmetic EGF is a lab-made copy of the human protein. On an ingredient list it appears as sh-Oligopeptide-1, where “sh” stands for synthetic human.

Stanley Cohen discovered EGF and shared the 1986 Nobel Prize in Physiology or Medicine with Rita Levi-Montalcini for the discovery of growth factors.

Cosmetic grades come from recombinant production. The human gene sequence goes into a host such as bacteria, yeast, or a plant, and the host makes the protein. One published study used EGF grown in barley (Schouest et al., 2012).

Watch the name. Oligopeptide-1, without the “sh”, is a different ingredient. China’s regulator spelled this out in 2019: oligopeptide-1 is a three-amino-acid peptide, while human oligopeptide-1 (EGF) is a 53-amino-acid protein of about 6,200 daltons. A quote that lists plain oligopeptide-1 is not an EGF quote.

The Mechanism Behind EGF, and Why Size Is the Catch

EGF works by docking onto the EGF receptor on skin cells, which switches on growth, migration, and repair signals. That makes it a wound-care molecule first. The catch for skincare is size, because intact skin keeps large molecules out.

A 2023 review in the International Wound Journal describes EGF as a regulator of cell survival, proliferation, migration, and differentiation in wound healing. In Korea, Daewoong Pharmaceutical sells a recombinant human EGF solution, Easyef, as a treatment for diabetic foot ulcers (The Korea Herald). The same molecule has a drug life and a cosmetic life.

The 500 Dalton rule refers to the observation that compounds that pass through healthy skin are usually smaller than 500 daltons (Bos and Meinardi, 2000). EGF is more than ten times that size. China’s regulator used the same logic, calling EGF hard to absorb through a normal barrier and a safety question once the barrier is broken.

That is why formulators pair EGF with delivery systems such as liposomes, and why clinics apply it after procedures that open the skin. For a US cosmetic brand, procedure language carries its own risk, covered below.

What Does the Clinical Evidence Actually Show?

The evidence is encouraging but thin. A 2023 systematic review found that growth factor serums improved the look of facial skin with few side effects. Most studies behind that result were small, uncontrolled, and hard to compare.

That review, by Quinlan, Ghanem, and Hassan, pooled 33 studies with 1,180 participants. Only 9 were randomized controlled trials, the products varied widely, and nobody yet knows whether results last beyond six months.

Martínez-Carpio frames the founder’s dilemma well. If a cosmetic EGF worked like the drug, it would be a drug. If it does not, the clinical story needs care. Either way, base claims on finished-product testing, as covered in our guide to HRIPT, clinical, and consumer testing for K-beauty claims.

Four Markets, Four Rulebooks for EGF

EGF’s legal status depends on where you sell. China bans it in cosmetics. Korea allows it but reserves anti-wrinkle claims for functional cosmetics. The US allows it while your claims stay cosmetic, and in the EU your safety assessor makes the call.

Most indie founders launch in the US first, so start with the FDA and MoCRA requirements for Korean skincare, then add markets one at a time.

Which Claims Can an EGF Serum Make in the US?

An EGF serum can make appearance claims, such as smoother-looking skin or a softer look of fine lines. It cannot claim to regrow, repair, or heal skin. FDA treats claims to affect the structure or function of the body as drug claims.

FDA’s guidance on cosmetics versus drugs is clear: intended use, shown by your claims, decides the category. Growth-factor marketing drifts toward drug language because the science is about cell growth. In 2012, FDA warned Lancôme USA over claims such as “boosts the activity of genes” (RAPS).

Under MoCRA, the responsible person must also keep records showing the product is safe. For EGF, that file starts with the raw material documents below.

Formulating With EGF: What Your ODM Will Watch

EGF is a protein, so heat, harsh pH, and microbial enzymes can break it down. Formulators add it late in the batch, keep the base gentle, and choose packaging that limits air and light.

Each extra active, such as PDRN or peptides, changes the stability plan, so test the final formula, not the single ingredient.

How Do You Brief a Korean ODM on an EGF Product?

Brief the ODM with five decisions already made: the exact INCI name, the raw material source, the documents you need, your target markets, and your claim list. Fixed inputs mean faster, more accurate quotes.

1. Name the ingredient exactly. Write “sh-Oligopeptide-1 (recombinant human EGF)” in the brief, and reject quotes that list plain oligopeptide-1.
2. Ask for the source. Get the raw material supplier, the host organism, and a certificate of analysis for each lot.
3. Ask for activity data. Request the supplier’s activity method and results, since critics question whether cosmetic grades are active.
4. Ask for purity documents. For bacteria-grown material, ask whether the supplier tests residual endotoxin. Your safety assessor will want that file.
5. Lock markets and claims. List every country you plan to sell in and draft claims before artwork. Keep “EGF” off any China-bound version.

For the rest of the document, use our Korean ODM brief template.

EGF in a Routine and in Your Product Line

EGF fits best in a leave-on step: a serum, ampoule, or cream used after cleansing and toner. In a product line, it can lead a recovery or firming serum, or support barrier ingredients in a cream.

In a routine, the EGF step comes before moisturizer, and daytime use still ends with sunscreen. Skip rinse-off formats, which give a protein little contact time.

For line planning, decide whether EGF is your hero or a supporting act. As a hero, it carries your claims, so the claim rules above matter most. As a supporting active, it adds a familiar K-beauty name to a formula whose claims rest on other ingredients.

If you are comparing hero actives, our heartleaf (Houttuynia cordata) sourcing guide shows how a calming botanical is briefed differently from a protein active.

Frequently Asked Questions

Can I sell an EGF serum on Tmall or Douyin?
Not as an EGF product. China’s NMPA stated in 2019 that EGF must not be used in cosmetics, and Alibaba’s Taobao also banned listings that mention EGF (ChemLinked). Plan an EGF-free version and remove the word from China-bound copy and images.

Can an EGF cream claim wrinkle improvement in Korea?
Only as a functional cosmetic reviewed by or reported to MFDS. The simple route uses a notified anti-wrinkle active, such as adenosine or retinol, so formulas that want the claim pair EGF with one of those.

Is barley-grown EGF different from EGF made in bacteria?
Both are recombinant copies of the human protein, and both carry the INCI name sh-Oligopeptide-1. The production host changes the impurity profile, so the documents differ: bacteria-grown material raises endotoxin questions, and plant-grown material needs its own purity data.

What does ppm mean on an EGF product page?
ppm means parts per million: one milligram of EGF per kilogram of product. Growth factors are dosed at very low levels, so ask which level the supplier’s activity data supports and write it into the brief.

By Liz Song, K-beauty sourcing consultant.